Naglazyme (galsulfase) treats a rare condition called Mucopolysaccharidosis VI (or Maroteaux-Lamy syndrome). It's given as an infusion into the veins by a healthcare provider, so it's not a medication you can pick up at the pharmacy. This medication can cause reactions during or after the infusion including fever, chills, trouble breathing, and nausea.
Naglazyme (galsulfase) is an enzyme replacement therapy (ERT), which means that it replaces an enzyme (protein) in your body. People with Mucopolysaccharidosis VI either don't have any or don't have enough of an enzyme that breaks down a certain sugar called glycosaminoglycan (GAG). GAG builds up in your body over time and can cause symptoms, such as bone changes, vision changes, and heart problems. Naglazyme (galsulfase) replaces the missing enzyme that breaks down the sugars, providing relief from some symptoms of Mucopolysaccharidosis VI.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur:
Less common
Blurred or decreased vision
difficult or labored breathing
dizziness
headache
hernia of the naval
nervousness
pounding in the ears
slow or fast heartbeat
swelling of the face
tightness in the chest
Incidence not known
Back pain
bluish lips or skin
confusion
dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
fever, chills, or sweating
hives or welts
joint pain
large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
loss of bladder control
loss of bowel control
nausea or vomiting
paralysis of the limbs
stomach pain
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Less common
Body aches or pain
burning, dry, or itching eyes
congestion
dryness or soreness of the throat
excessive tearing
loss of or increase in reflexes
runny or stuffy nose
tender, swollen glands in the neck
trouble with swallowing
unusual tiredness or weakness
voice changes
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Mucopolysaccharidosis VI is a rare, inherited condition where your body has lower levels of an enzyme, a specific protein, that breaks down a sugar called glycosaminoglycan (GAG). As a result, GAG builds up and causes cells in your body to get bigger. This then results in damage to many parts of your body, including the bones, lungs, and heart. Naglazyme (galsulfase) helps to replace this enzyme that you're missing so that your body can break down GAG and provide symptom relief.
No. Naglazyme (galsulfase) is considered a specialty medication, which means you will get it from a specialty pharmacy. Specialty pharmacies and infusion centers are used to dealing with medications like Naglazyme (galsulfase) that treat complicated or rare health conditions. The manufacturer has a savings program that might be able to offer resources to help you. Ask your healthcare provider or infusion center if you're interested in learning more.
Naglazyme (galsulfase) infusions should take at least four hours, but it also depends on how fast Naglazyme (galsulfase) is infused into your veins. Your healthcare provider will decide the infusion rate based on your weight. How long each treatment takes also depends on how well you tolerate the infusion. If you're experiencing infusion-related reactions (e.g., chills, nausea, or trouble breathing), your provider might need to slow down or temporarily stop the infusion to manage your symptoms. This will make the infusion take longer to finish.
Studies have shown that Naglazyme (galsulfase) works well to make it easier for people with Mucopolysaccharidosis VI to walk farther and climb more stairs. After just 6 months of using Naglazyme (galsulfase), people were able to walk 23% farther (in a 12-minute test) and were able to climb 38% more stairs (in a 3-minute test). Another study showed that Naglazyme (galsulfase) continued to improve endurance even after 10 years. If used at a young age, other possible benefits of using the medication include being able to breathe easier, growing taller, and slowing of bone- and heart-related problems.
Yes. People begin to show signs and symptoms of Mucopolysaccharidosis VI in early childhood. Studies with Naglazyme (galsulfase) included people ages 5 to 29, with the majority being children. For younger children between ages 3 to 12 months, some studies have shown that it might be safe and well tolerated. Your child's provider will decide if Naglazyme (galsulfase) is right for them.
Naglazyme (galsulfase) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Serious allergic reactions to Naglazyme (galsulfase) are possible. These reactions can include life-threatening problems like anaphylaxis (closing of the throat and difficulty breathing) and lower blood pressure. These reactions can happen during your infusion or up to 24 hours after your infusion has finished. Tell your provider right away if you begin to experience any of these symptoms during treatment. Your provider might stop the infusion and give you medications to help the symptoms go away. Your provider will decide if you should continue to receive Naglazyme (galsulfase).
Your provider might give you medications before your Naglazyme (galsulfase) infusion to help avoid infusion-related reactions. Let your provider know if you start to feel unwell at any point during the infusion or after you receive treatment. In clinical studies, over half of people experienced infusion-related reactions, including fever, chills, rash, nausea, vomiting, and trouble breathing. And these reactions happened anytime from the first infusion up to almost 3 years later.
If any of these reactions occur, your provider can adjust the infusion rate, temporarily stop the infusion, or give you medications to manage your symptoms. This might also mean you need to have medication before your next infusion to prevent or lessen the severity of these symptoms. If you've previously had an infusion-related reaction, your provider probably will want to observe you for a little while to see how you respond to the infusion in case they need to give you appropriate treatment.
People can experience abnormal immune system reactions after enzyme replacement therapies like Naglazyme (galsulfase). These reactions cause parts of your body, like your kidneys, to become inflamed and damaged. This type of reaction, which typically happens after you have received at least one infusion, might not occur very quickly and can take several days to develop. Symptoms of these reactions can include fever, weight loss, or fatigue. If you have an immune system reaction, your provider will decide if you should continue receiving Naglazyme (galsulfase) infusions.
People who have certain heart or lung problems are at higher risk for experiencing serious breathing problems when receiving a Naglazyme (galsulfase) infusion. Your provider might want to monitor you for longer to make sure you tolerate the infusion. Also if you have sleep apnea, remember to bring your oxygen or CPAP machine. Tell your provider immediately if you experience any chest pain, have trouble breathing, or feel too sleepy during your infusion.
Spinal or cervical cord compression (SCC) can naturally occur in people with Mucopolysaccharidosis VI. But it's possible that Naglazyme (galsulfase) might cause SCC to happen quicker or become worse and require surgery. This is when your spinal or cervical cord is being compressed (or squeezed), which can lead to loss of feelings or nerve function in certain parts of your body. Let your provider know if you start having more back pain, loss of feeling in arms or legs, or you are not able to control when you need to go to the bathroom.
Naglazyme (galsulfase) is given as an infusion into your veins (intravenous or IV) by a healthcare provider. The dose is based on your body weight. The typical dose is 1 mg/kg once a week given IV.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.